Alnuctamab for Refractory SLE (LATTE Study)
Clinical trial NCT07219563 · RECRUITING
Trial details
- NCT number
- NCT07219563
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2027-12-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.